COVIRNA is a patient-centred Innovation Action aiming to generate a diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications.
A joined-up EU wide approach to protecting our population.
Keep in touch
Sign up to our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
Identifying those at most risk from COVID-19
The overall goal of the COVIRNA project is to generate a diagnostic test based on cardiovascular RNA biomarkers highly predictive of the clinical outcomes of COVID-19 patients and to enable its rapid market uptake with the aim to improve individualised surveillance, care and follow-up of these patients in the context of the current pandemic.Find out more about the project
How we will do it
Our work packages are evolving, but include consideration and development of:
Existing & past
The LIH, through the Cardiovascular Research Unit of the Department of Population Health (DoPH), led by Dr Yvan Devaux, will be the Coordinator of “COVIRNA”. The consortium of organisations delivering COVIRNA includes:
News & Events
COVIRNA project to host a session at the EHMA 2022 Annual Conference
The COVIRNA project will be participating in the EHMA 2022 Annual Conference with the session ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’, on Friday, 17 June at 11:15 AM CET. EHMA 2022 Annual Conference&nbs…
COVIRNA project featured at the European events on cardiovascular medicine
In April, the COVIRNA project was featured at three European events focused on cardiovascular medicine. Dr Yvan Devaux, the COVIRNA Project Coordinator, represented the project at the final EU-CARDIOPROTECTION COST Action meeting on 2-4 April in Coimbra (Portugal), 2nd Olympiad in Cardiovascular …
lncRNA: Biomarker for diagnosing and prognosing cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading cause of death globally. According to the World Health Organisation, an estimated 17.9 million people die each year from CVDs. This represents 32% of all global deaths. CVDs are responsible for twice as many death as cancer in both men and women.&nbs…